Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of CKD on Clopidogrel Pharmacodynamics in T2DM and CAD
NCT03774394Phase 4Completed
- Sponsor
- University of Florida
- Start
- Aug 2019
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clopidogrel in coronary artery disease (CAD), sponsored by University of Florida. Started Aug 2019; status: completed.
02
Drugs
clopidogrel
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT03774394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03774394.